MétaCan
Menu
Back to cohort
Record W4409987123 · doi:10.1158/0008-5472.can-24-3425

Targeting Intracellular Innate RNA-Sensing Systems Overcomes Resistance to CAR T-cell Therapy in Solid Tumors

2025· article· en· W4409987123 on OpenAlexaff
Nardine Soliman, Tatiana Nedelko, Giada Mandracci, Stefan Enßle, Vincent Grass, Julius Fischer, Florian Bassermann, Hendrik Poeck, Sebastian Kobold, Nadia El Khawanky, Simon Heidegger

Bibliographic record

VenueCancer Research · 2025
Typearticle
Languageen
FieldImmunology and Microbiology
Topicinterferon and immune responses
Canadian institutionsOvarian Cancer Canada
FundersEuropean Research CouncilHector StiftungBayerisches Staatsministerium für Wirtschaft und Medien, Energie und TechnologieHector Stiftung IIDeutsche KrebshilfeTechnische Universität MünchenElitenetzwerk BayernJosé Carreras Leukämie-StiftungFritz-Bender-StiftungJung-Stiftung für Wissenschaft und ForschungBundesministerium für Bildung und ForschungLudwig-Maximilians-Universität MünchenDeutsche ForschungsgemeinschaftWilhelm Sander-StiftungEuropean CommissionHorizon 2020 Framework ProgrammeElse Kröner-Fresenius-StiftungBayerische ForschungsstiftungEuropean Hematology AssociationMelanoma Research Alliance
KeywordsIntracellularCancer researchRNAInnate immune systemSolid tumorCancerMedicineBiologyCell biologyImmunologyInternal medicineBiochemistryGeneImmune system

Abstract

fetched live from OpenAlex

Despite the remarkable success of chimeric antigen receptor (CAR) T cells in certain hematologic malignancies, only modest responses have been achieved in solid tumors. Defective cell death pathways have recently been suggested as a tumor-intrinsic form of resistance to CAR T-cell treatment. In this study, we showed that insufficient activity of the innate RNA-sensing receptor system retinoic acid-inducible gene I (RIG-I)/mitochondrial antiviral signaling protein (MAVS) leads to tumor cell-inherent resistance to CAR T-cell attack. Active RIG-I/MAVS signaling in tumor cells primed intrinsic mitochondrial apoptosis pathways and expression of cell death receptors, which funneled into CAR T-cell-triggered cell death. CAR T-cell reliance on tumor-intrinsic RIG-I signaling was observed in various murine and human cancer types, independent of the CAR construct used, and the dependence was most pronounced under conditions with low target antigen expression or low effector/target ratios. RIG-I-induced proapoptotic priming of CAR T-cell susceptibility involved auto-/paracrine type-I IFN signaling loops and could spread to bystander tumor cells. Strong tumor-intrinsic RIG-I/MAVS signaling imprinted an activated cytolytic phenotype on tumor-interacting CAR T cells. Agonist-mediated targeting of the RIG-I pathway in the tumor microenvironment rendered murine melanoma susceptible to CAR T-cell therapy in vivo with enhanced infiltration of active CAR T cells. Together, these data identify insufficient RIG-I/MAVS activity and associated impaired cell death signaling in malignant cells as a resistance mechanism to CAR T cells. Targeting tumor-intrinsic RIG-I is a potential strategy to sensitize solid tumors to CAR T-cell treatment. SIGNIFICANCE: Insufficient activity of the RIG-I/MAVS pathway is a tumor intrinsic resistance mechanism to CAR T cells, providing the rationale for targeting RIG-I to optimize CAR T efficacy in patients with solid cancers.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.003

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.032
GPT teacher head0.352
Teacher spread0.320 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicinterferon and immune responsesFrench-language works237,207